GAO finds gaps in the US FDA medical device recall procedures
This article was originally published in Clinica
Executive Summary
The US FDA's procedures for overseeing medical device recalls are unclear and represent a missed opportunity for the agency to proactively identify and address risks presented by unsafe devices, the Government Accountability Office has said in a report.